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ABSTRACT Fluorescence ﬂuctuation spectroscopy determines the brightness, size, and concentration of ﬂuorescent particles
from the intensity bursts generated by individual particles passing through a small observation volume. Brightness provides
a measure of the number of ﬂuorescently labeled proteins within a complex and has been used previously to determine the
stoichiometry of small oligomers in cells. We extend brightness analysis to large macromolecular protein complexes containing
thousands of proteins and determine their stoichiometry. This study investigates viral-like particles (VLP) formed from human
immunodeﬁciency virus type 1 (HIV-1) Gag protein expressed in COS-1 cells using ﬂuorescence ﬂuctuation spectroscopy to
determine the stoichiometry of HIV-1 Gag within the particles. Control experiments establish that the stoichiometry and size
of VLPs are not inﬂuenced by labeling of HIV-1 Gag with a ﬂuorescent protein. The experiments further show that the brightness
scales linearly with the amount of labeled Gag within the particle. Brightness analysis shows that the Gag stoichiometry of VLPs
formed in COS-1 cells is not constant, but varies with the amount of transfected DNA plasmid. We observed HIV-1 Gag stoichi-
ometries ranging from ~750 to ~2500, whereas the size of the VLPs remains unchanged. This result indicates that large areas of
the VLP membrane are void of Gag protein. Therefore, a closed layer of HIV-1 Gag at the membrane is not required for VLP
production. This study shows that brightness analysis has the potential to become an important tool for investigating large molec-
ular complexes by providing quantitative information about their size and composition.
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Fluorescence fluctuation spectroscopy (FFS) observes the
signal fluctuations generated by individual fluorescent parti-
cles passing through a small optical observation volume
(<1 fL). Statistical analysis of the fluctuations provides
information about sample properties (1). The most widely
used method, fluorescence correlation spectroscopy (FCS),
determines the concentration and temporal properties of
proteins from intensity correlation functions (2). Photon
counting histogram (PCH) and related techniques extract
the brightness and the average particle occupation number
within the observation volume from the data (3). The bright-
ness of a molecule is defined as the average fluorescence
intensity of a single particle. FCS and brightness analysis
are applied both in vitro and inside cells (4–9).
Brightness encodes the stoichiometry of a protein
complex. This concept was experimentally verified using
green fluorescent protein (GFP) as a marker and has been
applied to study the concentration-dependent dimerization
of nuclear receptors in living cells (10). Brightness analysis
was subsequently generalized to characterize the stoichiom-
etry of heteroprotein complexes by labeling with differently
colored fluorescent proteins (11,12). Thus far, brightness
analysis has been carried out on oligomers containing only
a few labeled proteins. W probe the stoichiometry of the
human immunodeficiency virus type-1 (HIV-1) Gag (group
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These particles contain hundreds to thousands of labeled Gag
molecules and represent a significantly more complex system
than previous applications of this technique.
Gag is crucial for the assembly of the HIV-1 virus. Exper-
iments have shown that expressing Gag in cells in the
absence of other viral proteins is sufficient for the production
and release of viral-like particles (VLP) with the same size as
authentic viral particles (13,14). Because VLPs are easy to
generate, are noninfectious and much simpler in composition
than the viruses, they constitute a model system for the study
of viral assembly. VLPs are enveloped by a lipid membrane
that the particle acquires from the host cells in the budding
process. During budding, a small vesicle (~140 nm diameter)
with Gag bound at the membrane is formed and released into
the extracellular medium. The stoichiometry or copy number
of Gag molecules residing on a single VLP or virion has been
the subject of numerous studies. The reported values vary
considerable, ranging from ~1000 to ~5000 (15–21). In
this study, we use fluorescence fluctuation spectroscopy
(FFS) to investigate the stoichiometry of Gag in VLPs
formed by HIV-1 Gag protein expressed in COS-1 cells.
The results of this study provide a plausible explanation
for the different HIV-1 Gag stoichiometries reported in the
literature. Our data also show that the formation of a closed
self-assembled layer of Gag is not required for VLP forma-
tion by cells, and establish the utility of brightness analysis
as a tool to gain quantitative information regarding the




Two-photon excitation with a Ti:sapphire laser was carried out at a wave-
length of 960 nm on a modified two-photon microscope as described earlier
(10). The viral particles are measured using a 63X Plan Apochromat oil
immersion objective (N.A. ¼ 1.4) with an excitation power of <0.3 mW.
FFS data are acquired at sampling frequencies ranging from 20 to
200 kHz and recorded for further analysis.
Expression vector and sample preparations
GagYFP vector (22) is a kind gift from Dr. Paul Spearman (Emory Univer-
sity). Cos-1 cells, obtained from ATCC (Manassas, VA), were maintained
in 10% fetal bovine serum and DMEM (without phenol red). Transfections
were carried out with transfectin according to manufacturer’s protocol
(BioRad, Hercules, CA). Cells were kept at ~70% confluency on the day
of transfection. For a typical viral particle experiment, 0.3 mg of vector is
diluted and mixed with 0.5 mL of transfectin. The transfection complex is
added to a cell culture plate with a growth area of 10 cm2. After 24 h post-
transfection, cell medium is collected and spun at 12,000  g for 2 min.
Concentrated HEPES buffer was immediately added to the supernatant to
a final concentration of 25 mM. The VLPs are either concentrated with
a Centricon filter at 16,000  g or purified by centrifugation at 40,000  g
for 2 h through sucrose cushion. A volume of 200 mL of VLP solution was
added to an 8-well Nunc Lab-Tek Chamber Slide (Thermo Fisher Scientific,
Pittsburgh, PA) and mounted on the two-photon microscope. A lid was
placed on the chamber slide to eliminate sample loss by evaporation.
FFS data analysis
The autocorrelation function calculated from the data is fit to a single species
diffusion model with a 3D-Gaussian point spread function to determine the
diffusion time tD (1). According to the Stokes-Einstein relation, the ratio of
the diffusion time of two samples is equal to the ratio of the hydrodynamic
radii of the diffusing particles, tD1/tD2 ¼ r1/r2. The measured diffusion time
of fluorescent spheres with a radius of 0.025 mm was used to calculate the
average diameter of the VLPs. The PCH function is calculated from
the FFS data. A single species is defined in PCH by its brightness 3 and
the average number N of particles in the optical observation volume (3).
Deadtime and afterpulsing corrections have been applied as described previ-
ously (23). If the molecular brightness contrast is sufficient, PCH analysis
successfully resolves a mixture of species without any additional informa-
tion about the sample (24). Fitting of PCH was carried out by programs
written in IDL (Research Systems, Boulder, CO). Error analysis of FFS
experiments has been carried out as described previously (24).
FFS brightness calibrations
All experiments are conducted in a power range where the fluorescence
intensity of YFP squares quadratically with the excitation power to ensure
the absence of unwanted optical effects. It was also confirmed that under
these conditions the brightness of YFP scales quadratically with excitation
power, whereas the average particle number N remained constant. These
results confirm that the observation volume is constant. At the low excitation
powers used for most VLP measurements long data acquisition times are
required for an accurate determination of the brightness and particle number
of YFP. Thus, to shorten the data acquisition time the brightness 3YFP of YFP
was determined by 3YFP ¼ Ilow/Nhigh, where Ilow is the intensity measured at
low power, whereas Nhigh is the particle number determined from a measure-
ment at a higher power.
The data acquisition time was chosen so that each FFS experiment records
at least 1000 VLPs traversing the observation volume to record a sufficient
number of fluctuations for statistical analysis of the data. VLPs are much
brighter than individual YFP molecules. To rule out the presence of satura-
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a VLP sample as a function of excitation power. The brightness per particle
and the average particle density was investigated over the power range from
0.1 mW to 0.7 mW by PCH analysis. To compensate for the loss of fluores-
cence signal at lower excitation powers we progressively increased the data
acquisition time from 30 min to 2 h to acquire sufficient statistics for accu-
rate analysis of the fluctuation data.
Determination of stoichiometry by brightness analysis relies on a well-
behaved fluorescent protein. We show in the Supporting Material that
YFP is suitable for quantitative brightness experiments.
Other data analysis
TEM studies were carried out on a Jeol JEM 1200-EX II microscope (Jeol
Ltd., Tokyo Japan). Purified viral samples are prepared and positively
stained using methanolic uranyl acetate (25). Viral samples were examined
by TEM at an accelerating voltage of 80 kV. Images were analyzed by soft-
ware written in IDL.
The SDS-PAGE gel is stained by SYPRO ruby protein gel stain and
imaged with a GE Typhoon Scanner. The integrated intensities FGag and
FGagYFP of the Gag and Gag
YFP bands are determined with software written
in IDL, which also corrects for the fluorescence background of the gel. The
fractional intensity ~x¼ FGagYFP/(FGag þ FGagYFP) is equal to the mole frac-
tion x of labeled Gag in the VLP sample, if Gag and GagYFP stain identically.
However, because the staining of the two proteins potentially differs, the
fractional intensity is only an approximate measure of the mole fraction of
labeled Gag.
RESULTS
Fluorescence fluctuation experiments were carried out on
VLPs prepared with yellow fluorescent protein (YFP)
-tagged HIV-1 Gag (22) expressed in COS-1 cells. A typical
fluorescence intensity trace is shown in Fig. 1 A. As evident
from this plot, the fluorescence intensity exhibits discrete
intensity spikes as a function of time. The intensity spikes
indicate very bright, but rare fluorescent particles diffusing
through the small two-photon excitation volume. The ampli-
tude of the spike intensity varies, reflecting the stochastic
nature of the diffusion path through the inhomogeneously
illuminated excitation volume. A particle passing through
the center of the volume ignites a much stronger burst of
photons than if the particle passes along the edge of the
volume. The probability distribution of the recorded photon
counts is shown in Fig. 1 B (square symbols). Photon count-
ing histogram (PCH) analysis was carried out on the proba-
bility distribution to determine both the brightness 3 and the
average number of particles in the optical observation
volume (3). For a complex with brightness 3 that contains
r proteins labeled with the fluorescent protein YFP, it is
useful to introduce the normalized brightness b as the ratio
of the brightness 3 of the protein complex to the brightness
3YFP of monomeric YFP, b ¼ 3/3YFP (12). Because bright-
ness scales with the number of fluorescent proteins in the
complex, the normalized brightness is a measure of the stoi-
chiometry r of the labeled protein within the complex, r ¼ b
(10,11).
A two-species model describes the experimental PCH
(reduced c2 ¼ 1.6). A c2 test with a significance level of
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Brightness Analysis of VLPs5% shows that an additional brightness species is not war-
ranted. In fact, if the data are fit to a model including an extra
brightness species, its parameters are not well-defined as
judged by a t-test. The photon count distribution of the first
species is well approximated by a Poissonianwith an intensity
of 580 counts per second. The Poisson distribution indicates
that the first species consists of many dim molecules with
a brightness close to zero. This fluorescent species represents
the autofluorescence background of the sample as confirmed
by a measurement of a sample prepared without viral parti-
cles. PCH analysis identifies this background in every VLP
sample measured. For simplicity, we will not report this back-
ground in the remainder of the article. The other species with
a brightness of 330,000 s1 and a particle density of 5 104
particles per excitation volume defines the VLPs. This value
of the brightness is 750 times higher than that of monomeric
YFP under identical experimental conditions. The normalized
brightness of b ¼ 750 indicates that a viral particle contains
on average 750 copies of GagYFP.
The same raw data were also analyzed by fluorescence
correlation spectroscopy. The autocorrelation function of
the data is shown in Fig. 1 C together with a fit to a single
species diffusion model with a diffusion time of 7.6 ms.
A single species fit is sufficient, because the autofluorescent
background is too weak to affect the fluctuation amplitude
of the autocorrelation function. The diffusion time translates
into a hydrodynamic diameter of 130 nm for the viral particles.
The presence of undesired optical effects such as satura-
tion and bleaching affect autocorrelation and PCH analysis
and result in a biased interpretation of the data. To exclude
such a bias, we carried out FFS measurements on a VLP
sample as a function of excitation power. The particle
density and the brightness per particle are shown in Fig. 2,
A and B, respectively, as a function of excitation power.
Because the excitation volume is power independent in the
absence of bleaching and saturation, the number of VLPs
within the excitation volume should be power independent,
as confirmed by the data in Fig. 2 A. Molecular brightness
of the particles, on the other hand, depends on the excitation
power. A fit of the data to a power law yields a power depen-
dence of 1.98, which agrees with the expected quadratic
power dependence of molecular brightness in the absence
of bleaching and saturation.
Tagging Gag with YFP could potentially interfere with the
assembly of VLPs. To rule out such complications, a number
of control experiments were carried out. We refer to particles
containing labeled protein as GagYFP VLPs, whereas unla-
beled particles are denoted as Gag VLPs. We first compared
FIGURE 1 FFS data for a VLP sample. (A) Fluorescence intensity time
trace. (B) PCH data (diamonds) and fit (solid line) to a two species model.
The first species is very dim with a brightness equal to that of a control
sample void of VLPs. The second, bright species has a normalized bright-
ness of ~750. (C) A fit of the autocorrelation function determined a hydrody-
namic diameter of 130 nm.
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the size of fluorescently tagged and untagged VLPs with
transmission electron microscopy (TEM). Images of posi-
tively stained VLPs are shown in Fig. 3. Although the two
samples stain differently, the images show a spherical cross
section for both cases. Image analysis of stained Gag VLPs
provides an average diameter of 129  12 nm (n ¼ 66),
whereas the average diameter of GagYFP VLPs is 130 
17 nm (n ¼ 33). We conclude that VLPs formed with Gag
and GagYFP have the same average size and shape.
For the next set of control experiments, cells were cotrans-
fected with a mixture of Gag and GagYFP plasmid. The Gag/
GagYFP VLPs harvested from cotransfected cells will simul-
taneously carry Gag and GagYFP. If labeling of Gag with
YFP does not interfere with assembly, then Gag and GagYFP
will be incorporated into the particle without preference. In
FIGURE 2 Power dependence of a VLP sample. (A) The concentration is
shown as a function of excitation power. PCH analysis determined the
average particle number N in the observation volume, which was converted
into a concentration by dividing by the observation volume. (B) The bright-
ness determined by PCH analysis is shown as a function of excitation power
together with a fit to a power law. The fitted exponent of 1.98 agrees within
error with the expected quadratic power-law dependence.
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VLPs will reflect the relative concentration of these proteins
within the cell. Conversely, if GagYFP negatively interferes
with assembly, we expect that viral particles will preferen-
tially incorporate Gag over GagYFP, which will lead to
VLPs enriched in Gag compared to its cellular concentration.
To vary the cellular concentration ratio of labeled and unla-
beled Gag, cells were transfected with different plasmid
mixtures of Gag/GagYFP. An assumption was made that the
composition of the plasmid mixture also determines the rela-
tive amount of expressed protein. If labeling does not affect
assembly, then the mole fraction x of labeled Gag protein
found in the particle should match the mole fraction y of
labeled plasmid. In contrast, if labeling interferes with particle
assembly, the mole fraction of labeled protein is not linearly
correlated with the mole fraction of labeled plasmid.
The normalized brightness b(x) of a Gag/GagYFP VLP
sample with a GagYFP mole fraction x is given by b(1)x,
where b(1) is the normalized brightness of pure GagYFP
VLPs. Note that this relationship also requires that the total
stoichiometry of labeled and unlabeled Gag in the VLP is
independent of the composition of the plasmid mixture.
For example, if labeling does not affect assembly, the
VLPs formed in cells transfected with a 1:1 mixture of
Gag and GagYFP (y ¼ 0.5) are expected to carry equal
amounts of Gag and GagYFP (x ¼ 0.5). The brightness of
the VLP sample is reduced, because only half of the Gag
proteins are fluorescent. If the total Gag stoichiometry is
750, the copy number of GagYFP is 375, which results in
a normalized brightness of b(0.5) ¼ 375.
Individual VLP samples were prepared by transfecting
cells with specific mole fractions of GagYFP/Gag plasmid.
FIGURE 3 Positively-stained transmission electron micrograph of VLP
samples. Two Gag VLP particles are shown on top of the figure, whereas
the bottom depicts two GagYFP VLP particles. Image analysis of 66 stained
Gag VLP particles determined an average diameter of 129 12 nm. Analysis
of 33 GagYFP VLP particles identified an average diameter of 130  17 nm.
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The brightness of the collected and concentrated viral parti-
cles was measured for each sample. Fig. 4 shows the normal-
ized brightness of Gag/GagYFP VLP samples as a function of
the mole fraction y of labeled Gag plasmid used for transfec-
tion. As expected, the normalized brightness or GagYFP copy
number is reduced with decreasing mole fraction of the
GagYFP plasmid. The solid line in Fig. 4 is a fit of the data
to the linear function, b(y) ¼ b(1) y, confirming that the
GagYFP copy number b(y) scales linearly with the mole frac-
tion of labeled Gag plasmid. This experiment was repeated
two times with identical outcomes. The linear relationship
between the GagYFP copy number of the VLPs and the
mole fraction of labeled Gag plasmid supports the assump-
tion that GagYFP does not alter the stoichiometry of the viral
particle.
To further support this result, we carried out an indepen-
dent biochemical assay on VLP samples by separating
Gag and GagYFP via denaturing polyacrylamide gel electro-
phoresis. Viral particles were collected from cells cotrans-
fected with different GagYFP and Gag plasmid mixtures,
concentrated and loaded onto a denaturing gel. The gel
was fluorescently stained and imaged (Fig. 5 A). The two
bands corresponding to Gag and GagYFP were clearly sepa-
rated and the integrated intensity of each band was quantified
by image analysis. Using these values, the fractional inten-
sity ~x of the GagYFP band relative to the total intensity of
the two Gag bands was determined. The fractional intensity
is an approximate measure of the mole fraction x of labeled
Gag in the VLP sample. Fig. 5 B displays the calculated frac-
tional intensity as a function of the mole fraction y of the
labeled Gag plasmid used for transfection. The data show
that the fractional intensity ~x not only scales linearly with
the mole fraction y of labeled Gag plasmid, but that both
FIGURE 4 Stoichiometry of GagYFP in the presence of unlabeled Gag.
VLPs produced from cells cotransfected with GagYFP and Gag plasmid.
The GagYFP copy number is shown as a function of mole fraction of labeled
Gag plasmid. The graph shows two sets of independent measurements.
A linear fit to the function b(y) ¼ b(1) y with b(1) ¼ 750 is shown as a solid
line.
Brightness Analysis of VLPsvalues are approximately the same, as illustrated by the solid
line ~x¼ y. In other words, the mole fraction of labeled protein
within VLPs is equal to the labeled plasmid mole fraction.
This result confirms that no preference of packaging Gag
over GagYFP exists.
We also determined the autocorrelation function of each
mixed Gag/GagYFP VLP sample. This analysis showed that
the diffusion time of the particle is unchanged within exper-
imental uncertainty. This result shows that the size of the
FIGURE 5 SDS-PAGE gel (12.5%) of VLP samples containing GagYFP
and Gag. (A) The mole fraction of labeled Gag plasmid is indicated at the
bottom of each lane. The bands are fluorescently stained with SYPRO
ruby protein gel stain and imaged. Two bands with positions that agree
with the molecular weights of Gag and GagYFP are present (bottom band:
Gag; top band: GagYFP; middle band: BSA from the cell medium).
(B) Mole fraction of GagYFP in VLPs containing a mixture of GagYFP and
Gag, as established by quantitation of bands on a denaturing polyacrylamide
gel. The graph displays the mole fraction of GagYFP protein as a function
of the mole fraction of labeled Gag plasmid used for cell transfection. The
line through the origin with a slope of one illustrates the linear relation-
ship between the protein mole fraction and the plasmid mole fraction.
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TABLE 1 FFS analysis of VLP samples prepared by transfection with different amounts of DNA
Plasmid (mg)
Brightness species 1 Brightness species 2
Diameter (nm)Gag copies N Gag copies N
0.15 750  40 (8.1  0.4) 104 130  24
0.60 1200  150 (4.1  0.6) 104 1600  240 (1.5  0.8) 104 130  18
0.90 1300  140 (6.7  0.7) 104 2500  220 (1.5  0.4) 104 130  20
PCH analysis identified two brightness species for transfection with 0.60 mg and 0.90 mg of plasmid. N is the average number of particles in the optical obser-
vation volume. The hydrodynamic diameter was determined from the autocorrelation function.
1966 Chen et al.particles is independent of the Gag/GagYFP composition of
the VLP sample.
PCH analysis of all VLP samples reported thus far identi-
fied a single brightness species associated with the particles.
Furthermore, all fluorescence fluctuation experiments point
to a stoichiometry of ~750 Gag proteins per particle. In these
initial experiments, the total amount of DNA used for trans-
fection (0.15 mg) was kept constant. To determine whether
the brightness properties of VLPs depend on the transfection
conditions, we carried out a series of experiments wherein
we transfected COS-1 cells with different amounts of
DNA. Several identical cell plates were transfected with
varying amounts of DNA plasmid, while keeping the amount
of transfection reagent constant. Supernatant from the indi-
vidual cell plates was collected and measured. The results
of the brightness analysis are reported in Table 1. Interest-
ingly, a single VLP brightness species failed to describe
the data when higher plasmid amounts were used and there-
fore, a second species was included in the analysis. The
normalized brightness was calculated to determine the
GagYFP copy number.
For the lowest amount of DNA transfection (0.15 mg), the
VLP sample is described by a single brightness species with
a stoichiometry of 750 copies of Gag per viral particle. Cells
transfected with 0.60 mg of DNA produced VLPs described
by two brightness species with stoichiometries of 1200 and
1600 copies of Gag per VLP. Transfection with 0.9 mg of
DNA resulted in two species with stoichiometries of 1300
and 2500 copies of Gag per particle. The data show that
raising the amount of transfected DNA results in an increase
of the Gag stoichiometry.
The autocorrelation function of each sample was calcu-
lated from the same data used for PCH analysis. In all cases,
a single diffusing species described the correlation functions.
The hydrodynamic diameter of the VLPs, which was calcu-
lated from the fitted diffusion time, is reported in Table 1.
The results indicate that the hydrodynamic size of the
VLPs is independent of the amount of transfected DNA.
DISCUSSION
The experiments on VLPs carried out in this study estab-
lished that FFS provides quantitative information about the
size and composition of large supramolecular complexes.
The brightness of these particles, which contain hundreds
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of the monomeric protein. To ensure a meaningful compar-
ison between the different experiments, we verified that all
FFS parameters are well-behaved over the relevant range
of excitation powers. The brightness of VLPs scales quadrat-
ically with power, whereas the diffusion time and the obser-
vation volume are power independent. This result also
confirms that optical trapping of the VLPs by the laser
beam is not occurring. Another potential concern is the finite
size of the particles, because FFS theory assumes point parti-
cles. To determine the effect of size on brightness we use
a theory that accounts for the finite size of particles (26).
The same method as presented for a ring structure is used
to derive the brightness bias for a shell, which is representa-
tive for the distribution of fluorophores of a VLP. Using Eq.
B2c of the theory presented in (26) we arrive at a relative bias
in brightness of ðð1þ 8a2=3Þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ 8a2=3rp Þ1  1; where
a is the dimensionless radius of the particle and r is the
squared beam waist ratio as defined in (26). We experimen-
tally determined r¼ 25 from a fit of the autocorrelation func-
tion. VLPs with a diameter of 130 nm correspond to a ¼
0.15, which leads to a brightness bias of 6%. In other
words, the experimentally measured brightness underesti-
mates the true brightness by 6%. This bias is negligible,
because it is of the same order as the experimental uncer-
tainty of the brightness measurement.
Some of our experiments used cells transfected with
a plasmid mixture of labeled and unlabeled Gag. Transfec-
tion with a plasmid mixture potentially leads to a wide distri-
bution of protein coexpression ratios, because of statistical
effects of plasmid uptake by the cell. The magnitude of
this statistical spread depends on the plasmid uptake. To
characterize the size of this effect we carried out a study
previously with dual-color detection on cells transfected
with plasmid mixtures of cyan and yellow fluorescent protein
(27). The cell-to-cell variations in protein coexpression ratio
ranged from 20% to 50%. In addition, the analysis showed
that the protein coexpression ratio exactly followed the
plasmid ratio. Based on this result it seems reasonable that
the coexpression ratio of labeled and unlabeled Gag is fairly
constant from cell to cell. This expectation is further sup-
ported by PCH analysis, which recovers a single brightness
species for the mixed VLP population. Thus, variations in
labeled and unlabeled Gag expression must be small enough
to be consistent with a single brightness description.
Previous studies suggested that labeling of Gag with fluo-
rescent proteins interferes with the proper assembly of VLPs
(28,29). However, TEM measurements showed no differ-
ence in the size distribution and shape of stained Gag and
GagYFP VLPs. It was also reported previously that VLPs
containing GagGFP appeared to create discontinuities in the
observed thin-section EM, whereas coexpression of labeled
and unlabeled Gag resulted in properly assembled particles
(29). Thus, studying VLP properties as a function of their
Gag/GagYFP composition provides a sensitive method of
detecting interference of particle assembly by GagYFP. Auto-
correlation analysis of mixed Gag/GagYFP VLPs showed that
the average size of the mixed VLPs is independent of the
GagYFP plasmid mole fraction. In addition, the GagYFP
copy number of the mixed Gag/GagYFP VLPs scaled linearly
with the GagYFP plasmid mole fraction. Taken together with
the results of a biochemical experiment, wherein the relative
amount of Gag and GagYFP present in mixed VLP samples
was quantified on denaturing polyacrylamide gels, these
studies show that the total copy number of labeled and unla-
beled Gag remains the same for all VLPs regardless of their
composition. The experiments also show that the GagYFP
copy number measured by brightness directly reflects the
mole fraction of labeled Gag, and support the conclusion
that the Gag copy number is accurately determined by bright-
ness. Interference with proper assembly should result in
observable differences in the VLP composition as the mole
fraction of labeled Gag approaches one. However, this
behavior was not observed. Instead, all experimental results
suggested that the composition of the VLP was not influ-
enced by labeling and that experiments with labeled Gag
reflect the properties of VLPs formed by unlabeled Gag
(Figs. 4 and 5).
Accurate determination of the Gag copy number requires
that the brightness of YFP is a stable quantity. As a first
indication that YFP is a suitable fluorophore we verified
that genetic tagging of YFP with a protein is not changing
brightness (data not shown). We have also shown that the
brightness of dimeric YFP doubles as compared to mono-
meric YFP (see Supporting Material), which shows the
absence of quenching or dark states. Note that both fluoro-
phores are in close enough proximity for homo-FRET to
occur. But unlike hetero-FRET, homo-FRET does not change
the brightness of the fluorophore. In addition, the fluorescence
lifetime of YFP in VLPs is identical to YFP in solution, which
excludes the presence of dynamic quenching. Additional
support that self-quenching of YFP does not occur in VLPs
is provided by the data in Fig. 4, which shows linear scaling
of brightness with the mole-fraction of labeled Gag.
Each FFS experiment reports the properties of an
‘‘ensemble of particles’’ rather than a single particle, because
the crossing of many different particles through the beam
contributes to the collected fluorescence fluctuations.
Ensemble measurements introduce population averaging,
which reduces the ability to distinguish between closely
Brightness Analysis of VLPsrelated species. For example, a sample with a Gaussian
distribution of particle sizes results in an autocorrelation
function that is, within error, identical to the correlation func-
tion of single-sized particles. The particle diameter deter-
mined from the diffusion time of the correlation function
equals the mean diameter of the Gaussian size distribution
if all particles have the same brightness. If larger particles
are brighter, then the diameter determined from the diffusion
time is slightly skewed to a larger than average size.
This discussion is relevant, because it is known that the
size distribution of the HIV-1 particles is heterogeneous.
Cryoelectron microscopy (cryo-EM) showed particle sizes
varying from 100 to over 200 nm, with an approximately
Gaussian distribution (30). The mean diameter identified
by the cryo-EM studies ranged from 130 to 150 nm. Our
TEM experiments showed a mean particle diameter of
130 nm. This value agrees with the particle diameter deter-
mined from the autocorrelation function.
Similarly, particles with a narrow distribution of bright-
ness values are described in FFS by a single averaged bright-
ness species, whereas a broader distribution of brightness
values would be identified as two or more discrete brightness
species. Thus, the observation of two brightness species in
some experiments most likely reflects the presence of
a heterogeneous population of VLPs with a broad distribu-
tion of Gag copy numbers. By the same token, the data
represented by a single brightness species most likely reflect
a VLP sample with a narrower distribution of Gag copy
numbers.
An intriguing finding of this study is the observation that
the Gag stoichiometry of VLPs depends on sample prepara-
tion. Using different amounts of plasmid for transfection
yielded VLPs with distinctly different stoichiometries. We
observed copy numbers of Gag ranging from 750 to 2500.
Our numbers overlap with earlier estimates of the Gag stoi-
chiometry carried out on VLPs and virions (16–18,20,21).
Our data suggest that the cellular concentration of Gag influ-
ences the stoichiometry. Higher amounts of plasmid used for
transfection yield a higher concentration of GagYFP inside
cells as judged from the fluorescence intensity, which corre-
lates with an increase in the measured stoichiometry. Tran-
sient transfection results in a heterogeneous population of
cells expressing Gag at different concentrations. Thus,
such a cell population would produce VLPs with a heteroge-
neous Gag stoichiometry, as experimentally indicated by the
presence of more than one brightness species. The lowest
copy number reported by us is less than the smallest value
(¼1400) quoted by EM (21). We may speculate that cryo-
EM studies use higher amounts of transfection agent,
because of the need to produce high concentrations of parti-
cles, which according to our study favors higher Gag copy
numbers. We tried to measure VLPs produced using higher
transfection amounts than quoted in Table 1, but were unsuc-
cessful because these samples contain large aggregated
structures that get trapped in the laser beam. Because of
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FIGURE 6 (Left) About 5000 copies of Gag protein are
required to cover the surface area of a 140-nm particle.
(Right) Our experimental data indicate that 750 copies of
Gag protein are sufficient to form viral like particles, which
corresponds to a surface coverage of ~15% as conceptually
illustrated in the figure. For simplicity, evenly distributed
Gag proteins are depicted. Recent data indicate that Gag
proteins exist in patches (19).
1968 Chen et al.this technical difficulty we are not able currently to explore
the Gag copy number of VLPs at higher transfection
amounts.
AhigherGagcopynumber (~5000)wasobtainedbya study
of particles assembled in vitro (15). It is known that Gag
assembles in solution into spherical shells with a size that
matches VLPs produced by cells. Under in vitro conditions,
self-assembly ofGag into particles is the only assemblymech-
anism available. The observed stoichiometry of 5000 Gag per
particle agrees well with the expected copy number based on
the known size of the Gagmolecule and the surface area of the
particle. Although geometrical constraints set an upper limit
of ~5000 to the Gag copy number of VLPs, a recent study
supports Gag stoichiometries of less than the maximum
copy number, because discontinuities in the electron density
along the membrane periphery of Gag bound to viral particles
were observed by cryo-EM (19). It was estimated that, on
average, only 40% of the viral surface is covered by a well-
ordered Gag lattice. This study provides a structural model
that is consistent with our brightness analysis.
The observation reported in this study that the Gag copy
number varies, whereas the size of the VLPs stays the
same, argues that self-assembly of Gag into a closed shell
is not a required mechanism for VLP assembly in cells.
Our observations imply that cells (i.e., cellular proteins or
factors) play an important role in determining the stoichiom-
etry of VLPs. It is known that Gag interacts with a number of
cellular proteins and lipids, which are involved in the
budding of particles (31). However, the role these cellular
factors play in the assembly process of the virus remains
an evolving story and requires further experimental charac-
terization (32,33).
No brightness heterogeneity was detectable for the lowest
amount of transfected plasmid (Table 1). This experiment
also yielded the lowest observed Gag copy number. Further
reduction of the transfected DNA resulted in very few VLPs
and could not be measured. Taken together, these data
suggest that a minimum Gag copy number is required for
VLP production by cells. In this study, a minimum copy
number of 750 was observed. Under these conditions,
only 15% of the lipid surface area is covered with Gag
protein (Fig. 6). Interestingly, it was experimentally esti-
Biophysical Journal 96(5) 1961–1969mated that the core of the mature virion contains ~1000-
1500 capsid proteins (34,35), whereas theoretical models
predict core formation with as little as 420 capsid proteins
(36). Because cleavage of each Gag molecule during the
maturation process of the virus yields one capsid protein,
the Gag stoichiometries observed here would yield a suffi-
cient number of capsid proteins for core formation. Thus,
from a biological point of view the observed Gag copy
numbers suffice for the formation of infectious virions
from immature particles.
CONCLUSIONS
In this study, brightness analysis has been extended to large
structures containing thousands of proteins. We successfully
showed that brightness is a measure of stoichiometry, as
illustrated by the linear relationship between brightness
and the mole fraction of labeled Gag proteins in VLPs.
Our data show that VLPs are successfully produced in
COS-1 cells over a wide range of HIV-1 Gag stoichiome-
tries. The size of the VLPs remained unchanged despite vari-
ations in the Gag copy number. This observation shows that
large areas of the VLP membrane are void of Gag protein.
Therefore, self-assembly of Gag into an enveloping protein
shell is not required for VLP formation by cells. Other
factors, such as protein and membrane interactions, are likely
to contribute significantly to the assembly of VLPs. Our
results suggest that the cellular Gag concentration is one
of the factors influencing the stoichiometry of Gag within
the VLP. We showed that changes in sample preparation
resulted in VLPs with different Gag copy numbers. This
observation offers a potential explanation for the differences
in the Gag copy number reported in the literature. By
analyzing mixed Gag/GagYFP VLPs, we showed that fluores-
cent labeling of Gag does not influence the properties of the
particle. Our results illustrate that FFS provides information
about the composition of particles that is difficult to obtain
by other methods. For example, a potential application of
FFS is the characterization of the amount of proteins carried
by vesicles. In summary, FFS promises to provide unique
contributions to the understanding of viral particles and other
complex structures.
SUPPORTING MATERIAL
Two tables are available at http://www.biophysj.org/biophysj/supplemental/
S0006-3495(09)00020-4.
We thank Dr. Paul Spearman (Emory University) for providing the Gag-
YFP plasmid.
This work was supported by grants from the National Institutes of Health
(GM64589 to J.D.M, GM065056 to K.M.-F. and AI57735 to L.M.M) and
the National Science Foundation (PHY-0346782 to J.D.M.).
REFERENCES
1. Thompson, N. L., A. M. Lieto, and N. W. Allen. 2002. Recent advances
in fluorescence correlation spectroscopy. Curr. Opin. Struct. Biol.
12:634–641.
2. Magde, D., E. Elson, and W. W. Webb. 1972. Thermodynamic fluctu-
ations in a reacting system: measurement by fluorescence correlation
spectroscopy. Phys. Rev. Lett. 29:705–708.
3. Chen, Y., J. D. Mu¨ller, P. T. C. So, and E. Gratton. 1999. The photon
counting histogram in fluorescence fluctuation spectroscopy. Biophys.
J. 77:553–567.
4. Berland, K. M. 2004. Fluorescence correlation spectroscopy: a new tool
for quantification of molecular interactions. Methods Mol. Biol.
261:383–398.
5. Hwang, L. C., and T. Wohland. 2007. Recent advances in fluorescence
cross-correlation spectroscopy. Cell Biochem. Biophys. 49:1–13.
6. Kohl, T., and P. Schwille. 2005. Fluorescence correlation spectroscopy
with autofluorescent proteins. Adv. Biochem. Eng. Biotechnol. 95:
107–142.
7. Kolin, D. L., and P. W. Wiseman. 2007. Advances in image correlation
spectroscopy: measuring number densities, aggregation states, and
dynamics of fluorescently labeled macromolecules in cells. Cell Bio-
chem. Biophys. 49:141–164.
8. Saffarian, S., Y. Li, E. L. Elson, and L. J. Pike. 2007. Oligomerization of
the EGF receptor investigated by live cell fluorescence intensity distri-
bution analysis. Biophys. J. 93:1021–1031.
9. Thompson, N. L., and B. L. Steele. 2007. Total internal reflection with
fluorescence correlation spectroscopy. Nat. Protocols. 2:878–890.
10. Chen, Y., L. N. Wei, and J. D. Mu¨ller. 2003. Probing protein oligomer-
ization in living cells with fluorescence fluctuation spectroscopy. Proc.
Natl. Acad. Sci. USA. 100:15492–15497.
11. Chen, Y., and J. D. Mu¨ller. 2007. Determining the stoichiometry of
protein hetero-complexes in living cells with fluorescence fluctuation
spectroscopy. Proc. Natl. Acad. Sci. USA. 104:3147–3152.
12. Chen, Y., L. N. Wei, and J. D. Mu¨ller. 2005. Unraveling protein-protein
interactions in living cells with fluorescence fluctuation brightness anal-
ysis. Biophys. J. 88:4366–4377.
13. Gheysen, D., E. Jacobs, F. de Foresta, C. Thiriart, M. Francotte, et al.
1989. Assembly and release of HIV-1 precursor Pr55gag virus-like
particles from recombinant baculovirus-infected insect cells. Cell.
59:103–112.
14. Karacostas, V., K. Nagashima, M. A. Gonda, and B. Moss. 1989.
Human immunodeficiency virus-like particles produced by a vaccinia
virus expression vector. Proc. Natl. Acad. Sci. USA. 86:8964–8967.
15. Briggs, J. A., M. N. Simon, I. Gross, H. G. Krausslich, S. D. Fuller, et al.
2004. The stoichiometry of Gag protein in HIV-1. Nat. Struct. Mol.
Biol. 11:672–675.
16. Layne, S. P., M. J. Merges, M. Dembo, J. L. Spouge, S. R. Conley, et al.
1992. Factors underlying spontaneous inactivation and susceptibility to
Brightness Analysis of VLPsneutralization of human immunodeficiency virus. Virology. 189:
695–714.
17. Piatak, M., Jr., M. S. Saag, L. C. Yang, S. J. Clark, J. C. Kappes, et al.
1993. High levels of HIV-1 in plasma during all stages of infection
determined by competitive PCR. Science. 259:1749–1754.
18. Vogt, V. M., and M. N. Simon. 1999. Mass determination of Rous
sarcoma virus virions by scanning transmission electron microscopy.
J. Virol. 73:7050–7055.
19. Wright, E. R., J. B. Schooler, H. J. Ding, C. Kieffer, C. Fillmore, et al.
2007. Electron cryotomography of immature HIV-1 virions reveals the
structure of the CA and SP1 Gag shells. EMBO J. 26:2218–2226.
20. Yeager, M., E. M. Wilson-Kubalek, S. G. Weiner, P. O. Brown, and
A. Rein. 1998. Supramolecular organization of immature and mature
murine leukemia virus revealed by electron cryo-microscopy: implica-
tions for retroviral assembly mechanisms. Proc. Natl. Acad. Sci. USA.
95:7299–7304.
21. Zhu, P., E. Chertova, J. Bess, Jr., J. D. Lifson, L. O. Arthur, et al. 2003.
Electron tomography analysis of envelope glycoprotein trimers on HIV
and simian immunodeficiency virus virions. Proc. Natl. Acad. Sci. USA.
100:15812–15817.
22. Derdowski, A., L. Ding, and P. Spearman. 2004. A novel fluorescence
resonance energy transfer assay demonstrates that the human immuno-
deficiency virus type 1 Pr55Gag I domain mediates Gag-Gag interac-
tions. J. Virol. 78:1230–1242.
23. Hillesheim, L. N., and J. D. Mu¨ller. 2003. The photon counting histo-
gram in fluorescence fluctuation spectroscopy with non-ideal photode-
tectors. Biophys. J. 85:1948–1958.
24. Mu¨ller, J. D., Y. Chen, and E. Gratton. 2000. Resolving heterogeneity
on the single molecular level with the photon counting histogram.
Biophys. J. 78:474–486.
25. Doultree, J. C., R. E. Kiernan, J. Y. Lee, D. S. Bowden, D. A. McPhee,
et al. 1992. A new electron microscope positive staining method for
viruses in suspension. J. Virol. Methods. 37:321–335.
26. Wu, B., Y. Chen, and J. D. Muller. 2008. Fluorescence correlation
spectroscopy of finite-sized particles. Biophys. J. 94:2800–2808.
27. Olmstead, S. 2004. Study of cotransfection and coexpression in cells.
MS thesis. University of Minnesota/Twin Cities.
28. Larson, D. R., M. C. Johnson, W. W. Webb, and V. M. Vogt. 2005.
Visualization of retrovirus budding with correlated light and electron
microscopy. Proc. Natl. Acad. Sci. USA. 102:15453–15458.
29. Pornillos, O., D. S. Higginson, K. M. Stray, R. D. Fisher, J. E. Garrus,
et al. 2003. HIV Gag mimics the Tsg101-recruiting activity of the
human Hrs protein. J. Cell Biol. 162:425–434.
30. Fuller, S. D., T. Wilk, B. E. Gowen, H. G. Krausslich, and V. M. Vogt.
1997. Cryo-electron microscopy reveals ordered domains in the imma-
ture HIV-1 particle. Curr. Biol. 7:729–738.
31. Resh, M. D. 2005. Intracellular trafficking of HIV-1 Gag: how
Gag interacts with cell membranes and makes viral particles. AIDS
Rev. 7:84–91.
32. Demirov, D. G., and E. O. Freed. 2004. Retrovirus budding. Virus Res.
106:87–102.
33. Yap, M. W., and J. P. Stoye. 2003. Bending out and breaking away:
host-cell accomplices in retroviral escape. J. Biol. 3:3.
34. Briggs, J. A., T. Wilk, R. Welker, H. G. Krausslich, and S. D. Fuller.
2003. Structural organization of authentic, mature HIV-1 virions and
cores. EMBO J. 22:1707–1715.
35. Li, S., C. P. Hill, W. I. Sundquist, and J. T. Finch. 2000. Image recon-
structions of helical assemblies of the HIV-1 CA protein. Nature.
407:409–413.
36. Nguyen, T. T., R. F. Bruinsma, and W. M. Gelbart. 2006. Continuum
theory of retroviral capsids. Phys. Rev. Lett. 96:078102.
Biophysical Journal 96(5) 1961–1969
1969
